Effect of vehicle on the nasal absorption of epinephrine during cardiopulmonary resuscitation

Pharmacotherapy

Volumn 16, Issue 6 I, 1996, Pages 1039-1045

  Bleske, Barry E ^a   Rice, Ted L ^a   Warren, Eric W ^a   Giacherio, Donald A ^a   Gilligan, Lori J ^a   Massey, Kenneth D ^a   Chrisp, Clarence E ^a   Tait, Alan R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BILE SALT; DRUG VEHICLE; PHENTOLAMINE; POLIDOCANOL; SODIUM CHLORIDE; SURFACTANT; TAURODEOXYCHOLIC ACID;

ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BLOOD LEVEL; EROSION; HEART VENTRICLE FIBRILLATION; INTRANASAL DRUG ADMINISTRATION; NONHUMAN; NOSE MUCOSA; RESUSCITATION; ULCER;

ADMINISTRATION, INTRANASAL; ADRENERGIC AGONISTS; ANIMALS; BLOOD PRESSURE; CARDIOPULMONARY RESUSCITATION; DETERGENTS; DOGS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EPINEPHRINE; NASAL MUCOSA; PHENTOLAMINE; POLYETHYLENE GLYCOLS; SINGLE-BLIND METHOD; TAURODEOXYCHOLIC ACID; VENTRICULAR FIBRILLATION;

EID: 0029849169     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Bleske BE, Warren EW, Rice TL, Shea MJ, Amidon G, Knight P. Comparison of intravenous and intranasal administration of epinephrine during CPR in a canine model. Ann Emerg Med 1992;21:1125-30.
2. Bleske BE, Rice TL, Warren EW, et al. Effect of dose on the nasal absorption of epinephrine during cardiopulmonary resuscitation. Am J Emerg Med 1996;14:133-8.
3. Donovan MD, Flynn GL, Amidon GL. The molecular weight dependence of nasal absorption: the effect of absorption enhancers. Pharm Res 1990;7:808-15.
4. Foti A, Kimura S, DeQuattro V, Lee D. Liquid-chromatographic measurement of catecholamines and metabolites in plasma and urine. Clin Chem 1987;33:2209-13.
5. Hill AB, Bowley CJ, Nahrwold ML, et al. Intranasal administration of nitroglycerin. Anesthesiology 1981;54: 346-8.
6. Pontiroli AE, Calderara A, Pozza G. Intranasal drug delivery. Potential advantages and limitations from a clinical pharmacokinetic perspective. Clin Pharmacokinet 1989;17: 299-307.
7. Salzman R, Manson JE, Griffing GT, et al. Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes. N Engl J Med 1985;312:1078-84.